Clinical trials
Phase 1 Brain Diseases trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2011 | 2 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Recruiting | 5 |
| Terminated | 3 |
| Unknown status | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 2 |
| AbbVie (prior sponsor, Abbott) | 1 |
| Alzheimer's Disease Expert Lab (ADEL), Inc. | 1 |
| Cerevel Therapeutics, LLC | 1 |
| Columbia University | 1 |
| Eli Lilly and Company | 1 |
| LeonaBio | 1 |
| Neurocrine Biosciences | 1 |
| Paul G. Harch, M.D. | 1 |
| Pfizer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Brain Diseases | 17 |
| Central Nervous System Diseases | 12 |
| Nervous System Diseases | 8 |
| Neurodegenerative Diseases | 7 |
| Mental Disorders | 5 |
| Brain Neoplasms | 4 |
| Dementia | 4 |
| Movement Disorders | 4 |
| Alzheimer Disease | 3 |
| Central Nervous System Neoplasms | 3 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.